Free tool
Dividend paying stocks
We cover 194 companies that currently pay a dividend. The median market value in the group is $16.25B. Across the group, the median move over the past trading day is 0.00%. 62% of the 190 with a 200-day average trade above it. Price change over the past year runs from −28.0% to +48.4% across the middle 80 percent of the group, with a median of +4.7%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
194 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.85% |
| GILD34.SA | Gilead Sciences, Inc. | $184.17B | Large cap | −78.95% |
| GIS.DE | Gilead Sciences, Inc. | $183.56B | Large cap | +29.53% |
| PFE.DE | Pfizer Inc. | $162.65B | Large cap | +18.09% |
| PFIZ34.SA | Pfizer Inc. | $161.64B | Large cap | +11.31% |
| PFE | Pfizer Inc. | $159.42B | Large cap | +19.52% |
| DHR | Danaher Corporation | $151.82B | Large cap | +4.52% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | −0.75% |
| DAP.DE | Danaher Corporation | $151.41B | Large cap | +5.45% |
| BMY | Bristol-Myers Squibb Company | $138.74B | Large cap | +49.31% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| BRM.DE | Bristol-Myers Squibb Company | $138.39B | Large cap | +46.24% |
| SYK | Stryker Corporation | $126.81B | Large cap | −14.79% |
| S1YK34.SA | Stryker Corporation | $126.62B | Large cap | −17.50% |
| SYK.DE | STRYKER CORP. R | $126.48B | Large cap | +34.76% |
| MDTC34.SA | Medtronic plc | $117.91B | Large cap | −76.08% |
| 2M6.DE | Medtronic plc | $117.39B | Large cap | +3.67% |
| MDT | Medtronic plc | $116.66B | Large cap | +1.33% |
| SNY | Sanofi | $110.27B | Large cap | −3.11% |
| SAN.PA | Sanofi | $110.15B | Large cap | −4.49% |
| SNW.DE | Sanofi | $109.49B | Large cap | −4.28% |
| MCK | McKesson Corporation | $105.52B | Large cap | +33.71% |
| GS71.DE | GSK plc | $104.54B | Large cap | +31.93% |
| G1SK34.SA | GSK plc | $104.53B | Large cap | +28.14% |
| GSK | GSK plc | $104.29B | Large cap | +34.79% |
| GSK.L | GSK plc | $104.16B | Large cap | +28.03% |
| M1CK34.SA | McKesson Corporation | $101.65B | Large cap | −92.48% |
| HCA | HCA Healthcare, Inc. | $95.12B | Large cap | +6.96% |
| H1CA34.SA | HCA Healthcare, Inc. | $92.89B | Large cap | +3.95% |
| A58.DE | Elevance Health, Inc. | $86.73B | Large cap | −18.92% |
| E1LV34.SA | Elevance Health, Inc. | $86.53B | Large cap | +21.66% |
| ELV | Elevance Health, Inc. | $86.50B | Large cap | +29.17% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $86.30B | Large cap | −7.35% |
| ESL.DE | EssilorLuxottica Société anonyme | $85.86B | Large cap | −38.59% |
| REGN | Regeneron Pharmaceuticals, Inc. | $85.82B | Large cap | +46.21% |
| EL.PA | EssilorLuxottica Société anonyme | $85.41B | Large cap | −37.89% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.24B | Large cap | +37.96% |
| CI | The Cigna Group | $73.81B | Large cap | −5.62% |
| C1IC34.SA | The Cigna Group | $73.40B | Large cap | −85.51% |
| CGN.DE | The Cigna Group | $73.25B | Large cap | −8.36% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $73.00B | Large cap | +12.47% |
| MRK.DE | Merck KGaA | $70.75B | Large cap | +30.60% |
| COR | Cencora, Inc. | $62.60B | Large cap | +14.44% |
| CSL.AX | CSL Limited | $59.98B | Large cap | −17.14% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.99B | Large cap | +39.50% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +21.77% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.23B | Large cap | +16.07% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.51B | Large cap | +71.10% |
| CAH | Cardinal Health, Inc. | $55.33B | Large cap | +64.25% |
| C1AH34.SA | Cardinal Health, Inc. | $55.24B | Large cap | +50.94% |
| BAY.WA | Bayer Aktiengesellschaft | $55.03B | Large cap | +71.25% |
| C1CO34.SA | Cencora, Inc. | $52.36B | Large cap | −12.17% |
| BOX.DE | Becton, Dickinson and Company | $52.05B | Large cap | +2.94% |
| SHL.DE | Siemens Healthineers AG | $51.88B | Large cap | −12.35% |
| B1DX34.SA | Becton, Dickinson and Company | $51.78B | Large cap | −113.87% |
| BDX | Becton, Dickinson and Company | $51.69B | Large cap | +26.17% |
| 7741.T | HOYA Corporation | $51.57B | Large cap | +29.26% |
| HUM | Humana Inc. | $46.42B | Large cap | +32.71% |
| H1UM34.SA | Humana Inc. | $45.80B | Large cap | +24.30% |
| HLN | Haleon plc | $44.77B | Large cap | +6.56% |
| H6D0.DE | Haleon plc | $44.53B | Large cap | +4.86% |
| HLN.L | Haleon plc | $44.36B | Large cap | +2.08% |
| A | Agilent Technologies, Inc. | $43.33B | Large cap | +30.69% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.62B | Large cap | +58.81% |
| A1GI34.SA | Agilent Technologies, Inc. | $39.64B | Large cap | −77.11% |
| ALC | Alcon Inc. | $35.47B | Large cap | −8.71% |
| RPRX | Royalty Pharma plc | $35.44B | Large cap | +75.10% |
| 2U3.DE | Alcon Inc. | $35.35B | Large cap | −10.05% |
| RMD | ResMed Inc. | $34.13B | Large cap | −16.58% |
| RMD.AX | ResMed Inc. | $34.05B | Large cap | −24.73% |
| GEHC | GE HealthCare Technologies Inc. | $33.62B | Large cap | −0.78% |
| 4568.T | Daiichi Sankyo Company, Limited | $33.36B | Large cap | −15.95% |
| ZTS | Zoetis Inc. | $31.94B | Large cap | −49.59% |
| 068270.KS | Celltrion, Inc. | $31.91B | Large cap | +13.47% |
| Z1TS34.SA | Zoetis Inc. | $31.90B | Large cap | −52.14% |
| ZOE.DE | Zoetis Inc. | $31.72B | Large cap | −50.09% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.15B | Large cap | +1.55% |
| 4503.T | Astellas Pharma Inc. | $27.40B | Large cap | +56.44% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +23.25% |
| R1MD34.SA | ResMed Inc. | $27.30B | Large cap | −38.24% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% |
| PHG | Koninklijke Philips N.V. | $26.81B | Large cap | +3.60% |
| PHI1.DE | Koninklijke Philips N.V. | $26.73B | Large cap | +2.84% |
| WST | West Pharmaceutical Services, Inc. | $24.52B | Large cap | +41.31% |
| 4543.T | Terumo Corporation | $24.11B | Large cap | −1.19% |
| SIG.AX | Sigma Healthcare Limited | $23.62B | Large cap | −5.33% |
| STE | STERIS plc | $23.05B | Large cap | −4.35% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $22.07B | Large cap | +10.02% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $22.06B | Large cap | +10.46% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.88B | Large cap | +26.10% |
| S1TE34.SA | STERIS plc | $19.75B | Large cap | −18.78% |
| VTRS | Viatris Inc. | $19.20B | Large cap | +62.88% |
| VIA.DE | Viatris Inc. | $19.14B | Large cap | +62.09% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.12B | Large cap | −5.86% |
| QS51.DE | Straumann Holding AG | $18.25B | Large cap | +0.41% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | $18.07B | Large cap | −5.04% |
| COLO-B.CO | Coloplast A/S | $16.31B | Large cap | −20.81% |
| CBHD.DE | Coloplast A/S | $16.19B | Large cap | +7.28% |
| IPN.PA | Ipsen S.A. | $16.01B | Large cap | +39.21% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.80B | Large cap | +13.60% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.72B | Large cap | +22.06% |
| 4507.T | Shionogi & Co., Ltd. | $15.68B | Large cap | +17.95% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $15.25B | Large cap | +5.51% |
| ERF.PA | Eurofins Scientific SE | $14.91B | Large cap | +13.76% |
| ESF0.DE | Eurofins Scientific SE | $14.63B | Large cap | +11.02% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +26.42% |
| PME.AX | Pro Medicus Limited | $14.09B | Large cap | −38.33% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +35.78% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +2.30% |
| BAX | Baxter International Inc. | $13.59B | Large cap | +7.91% |
| ORNBV.HE | Orion Oyj | $13.29B | Large cap | +16.59% |
| ORNAV.HE | Orion Oyj | $13.24B | Large cap | +17.12% |
| S1NN34.SA | Smith & Nephew plc | $12.87B | Large cap | −20.44% |
| FME.DE | Fresenius Medical Care AG | $12.66B | Large cap | −3.50% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.60B | Large cap | +2.09% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.29% |
| R1VT34.SA | Revvity, Inc. | $12.50B | Large cap | +22.81% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| SN.L | Smith & Nephew plc | $12.20B | Large cap | −21.69% |
| EHC | Encompass Health Corporation | $11.85B | Large cap | −1.16% |
| TECH | Bio-Techne Corporation | $11.27B | Large cap | +28.12% |
| T1CH34.SA | Bio-Techne Corporation | $11.23B | Large cap | +23.42% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.44% |
| BIM.PA | bioMérieux S.A. | $10.40B | Large cap | −37.52% |
| UHS | Universal Health Services, Inc. | $10.40B | Large cap | −4.14% |
| RDY | Dr. Reddy's Laboratories Limited | $10.28B | Large cap | −14.66% |
| U1HS34.SA | Universal Health Services, Inc. | $10.21B | Large cap | −10.02% |
| RHCPA.AX | Ramsay Health Care Limited | $10.16B | Large cap | +0.44% |
| R1DY34.SA | Dr. Reddy's Laboratories Limited | $9.95B | Mid cap | −21.76% |
| KRK.WA | Krka, d. d. | $9.12B | Mid cap | +31.52% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% |
| 4523.T | Eisai Co., Ltd. | $8.67B | Mid cap | +9.74% |
| BRKR | Bruker Corporation | $8.66B | Mid cap | +64.93% |
| ATR | AptarGroup, Inc. | $8.57B | Mid cap | −2.35% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +3.09% |
| 6869.T | Sysmex Corporation | $7.42B | Mid cap | +5.65% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +62.22% |
| 2413.T | M3, Inc. | $7.39B | Mid cap | −20.12% |
| RHC.AX | Ramsay Health Care Limited | $7.33B | Mid cap | +18.74% |
| ALK-B.CO | ALK-Abelló A/S | $7.23B | Mid cap | +8.24% |
| SHL.AX | Sonic Healthcare Limited | $7.20B | Mid cap | −11.60% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +19.61% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +21.56% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +58.61% |
| RADL3.SA | Raia Drogasil S.A. | $6.65B | Mid cap | +12.04% |
| HLUN-B.CO | H. Lundbeck A/S | $6.61B | Mid cap | +5.61% |
| HLUN-A.CO | H. Lundbeck A/S | $6.55B | Mid cap | +26.06% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.17% |
| COH.AX | Cochlear Limited | $6.38B | Mid cap | −53.16% |
| STVN | Stevanato Group S.p.A. | $6.08B | Mid cap | +3.23% |
| CTEC.L | Convatec Group PLC | $6.06B | Mid cap | −2.30% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| TFX | Teleflex Incorporated | $5.94B | Mid cap | +10.85% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −19.07% |
| GRFS | Grifols, S.A. | $5.44B | Mid cap | −17.62% |
| 000100.KS | Yuhan Corporation | $4.67B | Mid cap | −25.59% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.63B | Mid cap | −11.37% |
| OBCK.DE | Ottobock SE & Co. KGaA I | $4.51B | Mid cap | −0.82% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.47B | Mid cap | +80.49% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +49.74% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +22.31% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.04B | Mid cap | −0.90% |
| MCOV-B.ST | Medicover AB (publ) | $3.91B | Mid cap | −10.12% |
| 000105.KS | Yuhan Corporation | $3.88B | Mid cap | −31.05% |
| FIE.DE | Fielmann Group AG | $3.85B | Mid cap | −30.39% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.80B | Mid cap | +22.85% |
| 7459.T | MediPal Holdings Corporation | $3.77B | Mid cap | +14.74% |
| OGN | Organon & Co. | $3.61B | Mid cap | +52.78% |
| NHC | National HealthCare Corporation | $3.52B | Mid cap | +103.48% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.27B | Mid cap | −27.10% |
| AFX.DE | Carl Zeiss Meditec AG | $3.26B | Mid cap | −23.23% |
| BIOA-B.ST | BioArctic AB (publ) | $3.24B | Mid cap | +20.03% |
| VIRP.PA | Virbac SA | $3.22B | Mid cap | −2.81% |
| AMBU-B.CO | Ambu A/S | $3.20B | Mid cap | −19.61% |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.19B | Mid cap | −28.33% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $3.03B | Mid cap | −22.60% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.08% |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.00% |
| EBO.AX | EBOS Group Limited | $2.72B | Mid cap | −35.38% |
| 2784.T | Alfresa Holdings Corporation | $2.57B | Mid cap | +7.97% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.50B | Mid cap | +6.99% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.44B | Mid cap | +63.50% |
| DMP.DE | Dermapharm Holding SE | $2.43B | Mid cap | +14.86% |
| EKTA-B.ST | Elekta AB (publ) | $2.27B | Mid cap | +19.21% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.26B | Mid cap | +10.13% |
| XRAY | DENTSPLY SIRONA Inc. | $2.19B | Mid cap | −21.70% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +147.28% |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −11.16% |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% |
| GNS.L | Genus plc | $2.08B | Mid cap | −13.32% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +26.87% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +78.59% |
| PRGO | Perrigo Company plc | $2.01B | Mid cap | −36.97% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.